Literature DB >> 20107157

Prognostic relevance of CD20 in adult B-cell precursor acute lymphoblastic leukemia.

Hong Chang, Allan Jiang, Joseph Brandwein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20107157      PMCID： PMC2878810          DOI： 10.3324/haematol.2009.021089

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

1.  Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia.

Authors:  Deborah A Thomas; Susan O'Brien; Jeffrey L Jorgensen; Jorge Cortes; Stefan Faderl; Guillermo Garcia-Manero; Srdan Verstovsek; Charles Koller; Sherry Pierce; Yang Huh; William Wierda; Michael J Keating; Hagop M Kantarjian
Journal:  Blood       Date:  2008-08-14       Impact factor: 22.113

2.  Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia.

Authors:  Sima Jeha; Frederick Behm; Deqing Pei; John T Sandlund; Raul C Ribeiro; Bassem I Razzouk; Jeffrey E Rubnitz; Nobuko Hijiya; Scott C Howard; Cheng Cheng; Ching-Hon Pui
Journal:  Blood       Date:  2006-08-08       Impact factor: 22.113

3.  Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study.

Authors:  M J Borowitz; J Shuster; A J Carroll; M Nash; A T Look; B Camitta; D Mahoney; S J Lauer; D J Pullen
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

4.  Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

Authors:  L B Silverman; R D Gelber; V K Dalton; B L Asselin; R D Barr; L A Clavell; C A Hurwitz; A Moghrabi; Y Samson; M A Schorin; S Arkin; L Declerck; H J Cohen; S E Sallan
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

Review 5.  Treatment of adult acute lymphoblastic leukemia.

Authors:  Nicola Gökbuget; Dieter Hoelzer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

6.  Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

Authors:  Sébastien Maury; Françoise Huguet; Thibaut Leguay; Francis Lacombe; Marc Maynadié; Sandrine Girard; Adrienne de Labarthe; Emilienne Kuhlein; Emmanuel Raffoux; Xavier Thomas; Patrice Chevallier; Agnès Buzyn; André Delannoy; Yves Chalandon; Jean-Paul Vernant; Philippe Rousselot; Elizabeth Macintyre; Norbert Ifrah; Hervé Dombret; Marie-Christine Béné
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

7.  Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen.

Authors:  John M Storring; Mark D Minden; Susan Kao; Vikas Gupta; Andre C Schuh; Aaron D Schimmer; Karen W L Yee; Suzanne Kamel-Reid; Hong Chang; Jeffrey H Lipton; Hans A Messner; Wei Xu; Joseph M Brandwein
Journal:  Br J Haematol       Date:  2009-05-04       Impact factor: 6.998

8.  Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

Authors:  Françoise Huguet; Thibaut Leguay; Emmanuel Raffoux; Xavier Thomas; Kheira Beldjord; Eric Delabesse; Patrice Chevallier; Agnes Buzyn; André Delannoy; Yves Chalandon; Jean-Paul Vernant; Marina Lafage-Pochitaloff; Agnès Chassevent; Véronique Lhéritier; Elizabeth Macintyre; Marie-Christine Béné; Norbert Ifrah; Hervé Dombret
Journal:  J Clin Oncol       Date:  2009-01-05       Impact factor: 44.544
  8 in total
  7 in total

1.  CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease.

Authors:  Francesco Mannelli; Giacomo Gianfaldoni; Tamara Intermesoli; Chiara Cattaneo; Erika Borlenghi; Sergio Cortelazzo; Irene Cavattoni; Enrico Maria Pogliani; Monica Fumagalli; Emanuele Angelucci; Claudio Romani; Fabio Ciceri; Consuelo Corti; Anna Scattolin; Agostino Cortelezzi; Daniele Mattei; Ernesta Audisio; Orietta Spinelli; Elena Oldani; Alberto Bosi; Alessandro Rambaldi; Renato Bassan
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

Review 2.  Treatment of acute lymphoblastic leukemia in adolescents and young adults.

Authors:  Joseph M Brandwein
Journal:  Curr Oncol Rep       Date:  2011-10       Impact factor: 5.075

3.  The different predictive effects of the intensity and proportion of CD20 expression on the prognosis of B-lineage acute lymphocyte leukemia.

Authors:  Yun Tian; Xiaojiao Wang; Hao Ai; Xiaodong Lyu; Qian Wang; Xudong Wei; Yongping Song; Qingsong Yin
Journal:  EJHaem       Date:  2022-03-25

4.  CD20 expression sub-stratifies standard-risk patients with B cell precursor acute lymphoblastic leukemia.

Authors:  ShenMiao Yang; Jing Wang; Ting Zhao; JinSong Jia; HongHu Zhu; Hao Jiang; Jin Lu; Bin Jiang; HongXia Shi; YanRong Liu; YueYun Lai; LanPing Xu; XiaoJun Huang; Qian Jiang
Journal:  Oncotarget       Date:  2017-10-31

5.  Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL.

Authors:  Nataly Cruz-Rodriguez; Alba L Combita; Leonardo J Enciso; Lauren F Raney; Paula L Pinzon; Olga C Lozano; Alba M Campos; Niyireth Peñaloza; Julio Solano; Maria V Herrera; Jovanny Zabaleta; Sandra Quijano
Journal:  J Exp Clin Cancer Res       Date:  2017-02-28

6.  [Clinical analysis of adult Philadelphia chromosome-positive acute lymphoblastic leukemia with p16 gene deletion].

Authors:  B L He; N Xu; Y L Li; C Y Pan; R Cao; L B Liao; C X Yin; Y Q Lan; Z Y Lu; J X Huang; H S Zhou; Q F Liu; X L Liu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-03-14

7.  Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Na Xu; Yu-ling Li; Xuan Li; Xuan Zhou; Rui Cao; Huan Li; Lin Li; Zi-yuan Lu; Ji-xian Huang; Zhi-ping Fan; Fen Huang; Hong-sheng Zhou; Song Zhang; Zhi Liu; Hong-qian Zhu; Qi-fa Liu; Xiao-li Liu
Journal:  J Hematol Oncol       Date:  2016-04-18       Impact factor: 17.388
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.